Actavia Life Sciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Actavia Life Sciences Inc in the second quarter 2024?
Due to the lack of equity, it was not possible to calculate Actavia Life Sciences Inc 's return on equity (ROE) in its second quarter 2024

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2024) II. Quarter	(Dec 31 2023) I. Quarter	(Sep 30 2023) IV. Quarter	(Jun 30 2023) III. Quarter	(Mar 31 2023) II. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	0	-4	-4	-4	-5
Return On Equity (TTM)	-	-	-	-	-
RASP's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-2	-2	-2	-2	-2
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to RASP Management Effectiveness >> RASP's 5 Years Annual ROE >> Compare RASP ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

RASP Annual Return On Equity	(Sep 30 2023) 2023	(Sep 30 2022) 2022	(Sep 30 2021) 2021	(Sep 30 2020) 2020	(Sep 30 2019) 2019
Total Equity in Millions	-2	-2	-3	-3	3
Y / Y Equity Change	-	-	-	-	-18.3 %
Net Income in Millions	-4	-1	-1	-5	-1
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-36.9 %

Back to RASP Management Effectiveness >> RASP's 5 Years Annual ROE >> Compare RASP ROE to its Competitors

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RASP's' Return on Equity at Yahoo Finance
RASP's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RASP's Competitors
Subscribers only: Roe for Actavia Life Sciences Inc 's Suppliers
Subscribers only: Return On Equity for RASP's Customers

Companies with similar Return On Equity at Mar 31 2024, within Healthcare Sector	ROE
Johnson and Johnson	53.73 %
Eli Lilly And Company	53.13 %
Siga Technologies Inc	51.97 %
Elite Pharmaceuticals Inc	49.73 %
Zoetis Inc	48.39 %
Lite Strategy Inc	48.32 %
Collegium Pharmaceutical Inc	46.81 %
Protagonist Therapeutics inc	43.42 %
Kewaunee Scientific Corporation	42.26 %
Earth Science Tech Inc	41.28 %
Puma Biotechnology Inc	35.43 %
Insulet Corporation	34.86 %
Baxter International Inc	34.85 %
Star Equity Holdings Inc	34.71 %
Alkermes Plc	34.12 %
Prestige Consumer Healthcare Inc	31.73 %
Alaunos Therapeutics Inc	31.61 %
Agilent Technologies inc	30.63 %
Bruker Corporation	30.39 %
Semler Scientific inc	30.36 %
Spero Therapeutics Inc	30.04 %
Carlisle Companies Incorporated	29.47 %
Dexcom Inc	29.45 %
Msa Safety Inc	29.16 %
Innoviva Inc	28.33 %
Harmony Biosciences Holdings inc	28.26 %
Sbc Medical Group Holdings Incorporated	27.99 %
Chemed Corporation	26.59 %
Amphastar Pharmaceuticals Inc	24.79 %
Shockwave Medical Inc	24.79 %

Date modified: 2026-09-08T15:11:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.